{"ok":true,"trend":{"id":38631,"platform":"news","region":"global","key":"europe injects capital into colombian biotech firm to produce 250 million vaccines","title":"Europe Injects Capital into Colombian Biotech Firm to Produce 250 Million Vaccines","url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQTnBQWV9TZDFKdjU3Vk1OaVhDVnRJcVRHY0VCNGFTZ3ZTU1RLRkVrZlYwTlFwN3FRdlhGQ0dPWG02VTdST3dMM0FiWVJDd1JWa0lEUUo0LWNlX2sya2NvckwwZmhsd3ktUHl2eFhIMU1sbWpGVEFQTnpRLVRPLTBQczJhaXNTOU10d1lYT2xxLVVlZ1pPM3J5VWlfTDA0NE5lZWhvZzhlMzdkUnI5Qk4wMDBWX2tZVVhicmc?oc=5","first_seen":"2026-09-26T23:37:40.156967Z","last_seen":"2026-09-27T05:05:41.001351Z","last_rank":14,"peak_rank":14,"last_volume":null,"peak_volume":0,"seen_count":5,"score":44.99,"category_hint":"eu_politics","section":"world","category":"eu_politics","summary":"European investors are injecting capital into a Colombian biotechnology company with plans to produce 250 million vaccines. The deal signals growing confidence in Colombia's pharmaceutical sector and could expand regional vaccine manufacturing capacity, reducing reliance on imports. Details on the investors, funding amount and timelines have not yet been disclosed.","why":"News of fresh European investment in Latin American vaccine production is drawing attention amid ongoing interest in strengthening local manufacturing.","tone":"positive","entities":["Colombia","Europe","Colombian biotech firm"],"summarized_at":"2026-09-27T05:41:50.772709Z","meta":{"via":"scan","lang":"en","term":"european union","source":"ColombiaOne.com","generic":0.05,"published":"Sat, 26 Sep 2026 22:31:00 GMT"},"nw":0.62,"promo":0.03,"kind":"news_event","importance":2.21,"hidden":false,"hide_reason":null,"judged_at":"2026-09-26T23:37:40.503951Z","title_en":"European Capital Backs Colombian Biotech Firm to Make 250 Million Vaccines","section_name":"World","category_name":"EU Politics","timeline":[{"captured_at":"2026-09-26T23:37:40.156967Z","rank":14,"volume":null},{"captured_at":"2026-09-27T00:59:41.188133Z","rank":15,"volume":null},{"captured_at":"2026-09-27T02:21:41.268738Z","rank":18,"volume":null},{"captured_at":"2026-09-27T03:43:41.401743Z","rank":20,"volume":null},{"captured_at":"2026-09-27T05:05:41.001351Z","rank":14,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQTnBQWV9TZDFKdjU3Vk1OaVhDVnRJcVRHY0VCNGFTZ3ZTU1RLRkVrZlYwTlFwN3FRdlhGQ0dPWG02VTdST3dMM0FiWVJDd1JWa0lEUUo0LWNlX2sya2NvckwwZmhsd3ktUHl2eFhIMU1sbWpGVEFQTnpRLVRPLTBQczJhaXNTOU10d1lYT2xxLVVlZ1pPM3J5VWlfTDA0NE5lZWhvZzhlMzdkUnI5Qk4wMDBWX2tZVVhicmc?oc=5","author":"ColombiaOne.com","title":"Europe Injects Capital into Colombian Biotech Firm to Produce 250 Million Vaccines","snippet":null,"posted_at":"2026-09-26T22:31:00Z","likes":null}],"elsewhere":[],"window":"7d"}}